PMV Pharmaceuticals, Inc. (PMVP) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -19.68M | -17.19M | -19.82M | -18.3M | -18.27M | -16.66M | -16.84M | -1.6M | -16.18M | -12.09M | -15.66M | -12.9M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -7.74% | -3.17% | -17.7% | -1045.31% | -12.86% | -37.87% | -7.54% | 87.61% | -7.81% | 21.14% | 6.56% | 5.69% |
| Net Income | -18.04M | -18.04M | -21.06M | -21.21M | -17.44M | -23M | -19.23M | -1.21M | -15.27M | -15.76M | -16.64M | -17.44M |
| Depreciation & Amortization | 34K | 33K | 32K | 32K | 37K | 39K | 371K | 372K | 362K | 359K | 358K | 369K |
| Stock-Based Compensation | 1.39M | 0 | 0 | 1.67M | 1.51M | 1.27M | 2.22M | 2.77M | 2.61M | 2.97M | 3.32M | 3.15M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.84M | 0 |
| Other Non-Cash Items | -410K | 802K | 685K | -706K | -840K | 3.58M | -1.39M | -1.48M | -1.71M | -1.96M | -95K | -1.05M |
| Working Capital Changes | -2.66M | 13K | 522K | 1.91M | -1.53M | 1.45M | 1.18M | -2.05M | -2.17M | 2.31M | -764K | 2.07M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.52M | -244K | 801K | -995K | -2.99M | 4.52M | -2.47M | 3.68M | -2.38M | 1.55M | -1.81M | 2.01M |
| Cash from Investing | 20.82M | 18.44M | 12.03M | 10.99M | 28.71M | 7.74M | 17.12M | 2.32M | 26.17M | -2.59M | -33.64M | -63.96M |
| Capital Expenditures | 0 | -15K | 1K | -11K | -4K | -56K | -1K | -4K | -594K | -197K | -44K | -565K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 1K | 30K | 0 | 0 | 0 | 0 | 0 | 0 | 33.59K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 222K | 29K | 0 | 0 | 0 | -33.59K | 0 |
| Cash from Financing | 0 | 392K | 0 | 103K | 10K | 172K | 0 | 141K | 0 | 288K | 33.15M | 2.13M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 392K | 0 | 103K | 0 | 0 | 0 | 0 | 0 | 288K | 33.09M | 2.13M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 10K | 172K | 0 | 141K | 0 | 0 | 51K | 0 |
| Net Change in Cash | 1.15M | 1.65M | -7.79M | -7.21M | 10.46M | -8.76M | 284K | 872K | 9.95M | -14.35M | -16.15M | -74.73M |
| Free Cash Flow | -19.68M | -17.2M | -19.82M | -18.31M | -18.27M | -16.72M | -16.84M | -1.6M | -16.78M | -12.28M | -15.7M | -13.47M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -7.71% | -2.91% | -17.69% | -1043.13% | -8.89% | -36.11% | -7.24% | 88.1% | -10.61% | 27.59% | 16.51% | 21.61% |
| FCF per Share | -0.37 | -0.32 | -0.37 | -0.35 | -0.35 | -0.32 | -0.33 | -0.03 | -0.33 | -0.24 | -0.32 | -0.29 |
| FCF Conversion (FCF/Net Income) | 1.09x | 0.95x | 0.94x | 0.86x | 1.05x | 0.72x | 0.88x | 1.32x | 1.06x | 0.77x | 0.94x | 0.74x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |